Annual SG&A:
$23.82M+$9.53M(+66.63%)Summary
- As of today, MLYS annual SG&A is $23.82 million, with the most recent change of +$9.53 million (+66.63%) on December 31, 2024.
- During the last 3 years, MLYS annual SG&A has risen by +$21.41 million (+885.60%).
- MLYS annual SG&A is now at all-time high.
Performance
MLYS SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$6.57M(-100.00%)Summary
- As of today, MLYS quarterly SG&A is $0.00, with the most recent change of -$6.57 million (-100.00%) on June 30, 2025.
- Over the past year, MLYS quarterly SG&A has dropped by -$5.89 million (-100.00%).
- MLYS quarterly SG&A is now -100.00% below its all-time high of $6.57 million, reached on March 31, 2025.
Performance
MLYS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.29B-$190.77M(-17.37%)Summary
- As of today, MLYS TTM SG&A is -$1.29 billion, with the most recent change of -$190.77 million (-17.37%) on June 30, 2025.
- Over the past year, MLYS TTM SG&A has dropped by -$1.31 billion (-7141.59%).
- MLYS TTM SG&A is now -5500.90% below its all-time high of -$23.01 million.
Performance
MLYS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
MLYS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +66.6% | -100.0% | -7141.6% |
| 3Y3 Years | +885.6% | -100.0% | -10000.0% |
| 5Y5 Years | +4377.8% | -100.0% | -10000.0% |
MLYS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +885.6% | -100.0% | at low | -1830.9% | at low |
| 5Y | 5-Year | at high | +4377.8% | -100.0% | at low | -5500.9% | at low |
| All-Time | All-Time | at high | +4377.8% | -100.0% | at low | -5500.9% | at low |
MLYS Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $12.69M(-31.7%) |
| Mar 2025 | - | $6.57M(>+9900.0%) | $18.58M(+11.8%) |
| Dec 2024 | $23.82M(+66.6%) | $0.00(-100.0%) | $16.62M(-19.5%) |
| Sep 2024 | - | $6.12M(+3.8%) | $20.65M(+12.8%) |
| Jun 2024 | - | $5.89M(+27.9%) | $18.30M(+12.6%) |
| Mar 2024 | - | $4.61M(+14.5%) | $16.26M(+13.7%) |
| Dec 2023 | $14.30M | $4.03M(+6.7%) | $14.30M(+14.7%) |
| Sep 2023 | - | $3.77M(-2.0%) | $12.46M(+24.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $3.85M(+45.6%) | $10.05M(+41.9%) |
| Mar 2023 | - | $2.65M(+20.8%) | $7.08M(+59.6%) |
| Dec 2022 | $5.23M(+116.3%) | $2.19M(+60.6%) | $4.44M(+63.5%) |
| Sep 2022 | - | $1.36M(+54.3%) | $2.71M(+101.0%) |
| Jun 2022 | - | $884.00K(+89.3%) | $1.35M(+189.3%) |
| Dec 2021 | $2.42M(+354.3%) | - | - |
| Dec 2021 | - | $467.00K | $467.00K |
| Dec 2020 | $532.00K | - | - |
FAQ
- What is Mineralys Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. annual SG&A year-on-year change?
- What is Mineralys Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Mineralys Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. TTM SG&A year-on-year change?
What is Mineralys Therapeutics, Inc. annual SG&A?
The current annual SG&A of MLYS is $23.82M
What is the all-time high annual SG&A for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high annual SG&A is $23.82M
What is Mineralys Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, MLYS annual SG&A has changed by +$9.53M (+66.63%)
What is Mineralys Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of MLYS is $0.00
What is the all-time high quarterly SG&A for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high quarterly SG&A is $6.57M
What is Mineralys Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, MLYS quarterly SG&A has changed by -$5.89M (-100.00%)
What is Mineralys Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of MLYS is -$1.29B
What is the all-time high TTM SG&A for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high TTM SG&A is -$23.01M
What is Mineralys Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, MLYS TTM SG&A has changed by -$1.31B (-7141.59%)